Azenta Inc. (AZTA:NASD) - Strategic SWOT and Financial Analysis - A Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence and Financial and Operational KPIs, and Recent Trends
Report Summary Azenta Inc. Strategic SWOT Analysis and Financial Insights - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, and Recen... もっと見る
日本語のページはAI翻訳を利用し作成しています。
SummaryReport SummaryAzenta Inc. Strategic SWOT Analysis and Financial Insights - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, and Recent Trends Report is a comprehensive and easily accessible overview of Azenta Inc.'s business operations. It provides a detailed analysis of the company's financial and strategic standing, as well as its position in the industry compared to competitors. The report includes several key features to facilitate decision-making and provide insights into the company's performance. The report begins with in-depth information about Azenta Inc. including key insights, business segments, key executives, locations, products and services, historical events, corporate strategy, and management discussions. This section provides a solid foundation for understanding the company's key attributes. Next, the report assesses Azenta Inc.'s strategic standing through various analyses. The ESG spotlight evaluates the company's environmental, social, and governance performance, providing insights into its sustainability efforts and ethical practices. The SWOT analysis examines the company's internal strengths and weaknesses, as well as external opportunities and threats. Additionally, By integrating these strategic analyses, the report offers a comprehensive understanding of Azenta Inc.'s overall strategic standing and supports informed decision-making and strategic planning. The report also covers Azenta Inc.'s financial analysis basis of latest income statement, balance sheet, and cash flow statement. Key financial ratios related to profitability, asset turnover, credit, market, and long-term solvency are outlined, providing guidance for investment decisions. Furthermore, the report compares Azenta Inc.'s financial parameters with those of its competitors, offering a unique analysis of the competitive landscape. This information helps manage the business environment and improve sales activities by gaining insight into competitors' operations. Finally, the report includes recent news and deal activities undertaken by Azenta Inc. enhancing awareness of the company's business trends, growth perspectives, and more. Key Highlights Azenta Inc., founded in 1978 and formerly known as Brooks Automation until its rebranding in December 2021, is a leading provider of innovative life sciences solutions. Headquartered at 200 Summit Drive in Burlington, Massachusetts, United States, the company drives advancements in sample management, automation, genomics, and cryogenic storage to accelerate scientific discoveries and therapies. Operating primarily in the healthcare sector specifically medical instruments and supplies Azenta delivers products and services across two key segments: Life Sciences Products and Life Sciences Services. These offerings support experimental design, gene sequencing, sample analysis, and consultation for biotech and pharmaceutical clients worldwide. Azenta maintains a robust global presence, with significant market share in North America, Europe (including the U.K. and Rest of Europe), Asia-Pacific, and China. Laboratories, biorepositories, and manufacturing facilities span these regions, enabling efficient service to international customers while employing around 3,300 professionals. This strategic footprint underscores Azenta's commitment to fostering breakthroughs in life sciences on a global scale Azenta Inc. in the News:- 2026-05-21 - Azenta Publishes 2025 Environmental, Social, and Governance (ESG) Report 2026-05-05 - Azenta Reports Second Quarter Results for Fiscal 2026, Ended March 31, 2026, Updates Full Year Fiscal 2026 Guidance, and Extends Long-Range Plan to 2029 2025-07-31 - Azenta Life Sciences Partners with Frenova, a Division of Fresenius Medical Care, and Nephronomics to Advance Genomic Research in Nephrology 2025-01-30 - Azenta Announces the Election of Dipal Doshi to its Board of Directors 2025-01-23 - UK Biocentre Selects the Azenta Life Sciences BioArc Ultra Automated Storage System to Advance Research Excellence Scope • Tactical Analysis:- Various strategic frameworks to gain insights into a Azenta Inc.'s competitive position and operational environment. These analytical tools assist in identifying competitive advantages, potential risks, and areas for improvement and efficiency, enabling companies to make informed tactical decisions. • Business Strategy:- Contributes to shaping the Azenta Inc.'s overall direction, goals, and decision-making processes, ensuring long-term success and alignment with stakeholder expectations. • Financial Position:- Provide valuable information on the financial performance and investor sentiment surrounding the company. Indicating the level of confidence and expectations in the company's future prospects. These components collectively contribute to understanding the financial health and market perception of the company. • Company Fundamentals:- These fundamentals offer valuable insights into the company's history, operations, leadership, and geographical presence, aiding in a comprehensive understanding of the organization. • Competitive Landscape:- An identification of the Azenta Inc.'s main competitors, providing insights into the competitive landscape it operates in. Reasons to Buy • Comprehensive Understanding of the Azenta Inc.'s internal and external factors through SWOT analysis, Financial Analysis, and Competitors Benchmarking. • Strive Strategic Decision Making with various analyses and identifying potential customers and suppliers. • Mitigate Risk with help of thorough analysis of internal and external factors. Furthermore, develop strategies and contingency plans to address these challenges and minimize their impact on business operations. • Competitive Benchmarking will help to gain a competitive advantage by understanding industry trends, customer preferences, and best practices. • Financial Performance Evaluation provides crucial insights into key financial ratios and trends, supporting better financial decision-making and resource allocation. • Valuable insights from the report enable investors and partners to make informed decisions regarding potential Collaborations, Investments, or Partnerships with the company. Additionally, available deep-dive analysis on the company Azenta Inc.: • Azenta Inc. PESTLE Analysis • Azenta Inc. Value Chain Analysis • Azenta Inc. Porter's Five Forces Analysis • Azenta Inc. VRIO Analysis • Azenta Inc. BCG Analysis • Azenta Inc. Segmentation, Targeting and Positioning (STP) Analysis • Azenta Inc. Ansoff Matrix Analysis Table of ContentsTable of Contents 2Tables 5 Charts 6 Azenta Inc. - Key Company Facts 7 Azenta Inc. - Company Description 8 Azenta Inc. - Top Executives 9 Azenta Inc. - Head Office & Locations 10 Head Office - Country 10 Azenta Inc. - Products and Services 11 Products 11 Services 12 Azenta Inc. - Corporate Strategy 13 Azenta Inc. - Business Description 17 Sample Management Solutions 17 Multiomics 18 Azenta Inc. - ESG Spotlight 20 Environment 20 Social 21 Corporate Governance 22 Azenta Inc. - SWOT Analysis 24 Overview 24 Strengths 26 Weaknesses 29 Opportunities 31 Threats 32 Azenta Inc. - Financial Deep Dive 34 Share Price Trend - Jun-2025 to Jun-2026 (Average Share Closing Price) 34 Profit and Loss Statement 36 Summary of Profit and Loss Statement 36 Balance Sheet 40 Summary of Balance Sheet 40 Cash Flow Statement 44 Summary of Cash Flow Statement 44 Key Financial Ratio Analysis 48 Azenta Inc. - Ratio Charts 50 Activity Ratio Charts 50 Growth Ratios Charts 51 Leverage Ratio Charts 55 Liquidity Ratio Charts 57 Profitability Ratio Charts 59 Competing Players 61 Snapshot of Competing Players 62 Eurofins Scientific SE 62 Key Company Facts 62 Company Description 62 Key Financials 63 Share Price Trend - Jun-2025 to Jun-2026 (Average Share Closing Price) 63 Key Financial Ratio Analysis 68 Laboratory Corporation of America Holdings 70 Key Company Facts 70 Company Description 70 Key Financials 71 Share Price Trend - Jun-2025 to Jun-2026 (Average Share Closing Price) 71 Key Financial Ratio Analysis 76 Thermo Fisher Scientific Inc 78 Key Company Facts 78 Company Description 78 Thermo Fisher Scientific Inc. - SWOT Spotlight 79 Thermo Fisher Scientific Inc. - PESTLE Spotlight 81 Key Financials 83 Share Price Trend - Jun-2025 to Jun-2026 (Average Share Closing Price) 83 Key Financial Ratio Analysis 88 GenScript Biotech Corporation 90 Key Company Facts 90 Company Description 90 Key Financials 91 Share Price Trend - Jun-2025 to Jun-2026 (Average Share Closing Price) 91 Key Financial Ratio Analysis 96 BGI Genomics Co Ltd 98 Key Company Facts 98 Company Description 98 Key Financials 99 Share Price Trend - Jun-2025 to Jun-2026 (Average Share Closing Price) 99 Key Financial Ratio Analysis 104 Azenta Inc. - In the News 106 31-Jul-2025 - Azenta Life Sciences Partners with Frenova, a Division of Fresenius Medical Care, and Nephronomics to Advance Genomic Research in Nephrology 106 Azenta Inc. - Key Deals 108 04-Jun-2025 - Azenta Announces Collaboration with the Crohn's & Colitis Foundation to Support its Crohn's Disease and Ulcerative Colitis Clinical Research 108 13-May-2025 - Azenta Life Sciences and Form Bio Announce Strategic Partnership to Advance AAV Gene Therapy Development 109 Appendix 110 Definitions 110 SWOT Analysis 110 PESTLE Analysis 110 Value Chain Analysis 110 ESG Spotlight 110 Financial Deep Dive 110 Financial Ratios 111 Activity Ratios 111 Growth Ratios 113 Leverage Ratios 116 Liquidity Ratios 118 Market Ratios 120 Profitability Ratios 122 Research Methodology 124 Disclaimer 125 Contact Us 125
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療/ヘルスケア)の最新刊レポート
Quaintel Research社の 医薬品・医療分野 での最新刊レポート
本レポートと同じKEY WORD(corporate)の最新刊レポート
よくあるご質問Quaintel Research社はどのような調査会社ですか?Quaintel Researchはインドを拠点をとする調査会社です。 様々な企業の分析を行っており、企業の競合分析に役立つ資料をご提供します。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|